JANX
Janux Therapeutics Inc
16.60$
-1.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 3.4% | 1,005.4% | 879.0% | 24.2% | 19.5% | 20.3% | |
| – | -3.4% | 100.0% | 100.0% | 75.8% | 80.5% | 79.7% | |
| – | 800.3% | 721.4% | 620.5% | 679.5% | 645.9% | 1,259.0% | |
| – | 474.2% | 284.0% | 258.5% | 323.4% | 387.7% | 417.7% | |
| – | 1,271.1% | 1,005.4% | 879.0% | 978.7% | 1,014.1% | 1,656.4% | |
| – | -1,274.5% | -905.4% | -779.0% | -902.9% | -933.6% | -1,576.7% | |
| – | 54.2% | 10.2% | 46.8% | – | – | – | |
| – | -1,785.3% | -898.3% | -732.2% | -721.2% | -651.6% | -1,136.3% | |
| – | -402.4% | -3.1% | -103.4% | 22.1% | – | – | |
| – | -1,785.3% | -895.2% | -628.8% | -721.2% | -651.6% | -1,136.3% | |
| – | -1,727.6% | -902.3% | -769.3% | -697.0% | -632.2% | -1,116.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.